Non-drug ways and gene therapy to boost deep sleep brain cleaning in Alzheimer's models
Official title: Multifaceted approaches modulate slow-wave activity as therapeutic interventions in mouse models of Alzheimer's disease: Drug-free therapy, pharmaceutical therapy and gene-therapy
Funded at Boston VA Research Institute, INC. · NIH-11606008 · Data updated 2026-11-12
This project tests three patient-friendly ideas to boost slow-wave brain activity in models of Alzheimer's disease, aiming to improve brain cleaning, reduce amyloid buildup, and boost memory-like tasks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston VA Research Institute, INC. NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 15, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $617,796 |
| NIH project number | 1R56AG098813-01 |
| Project ID | NIH-11606008 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals with early to mid-stage Alzheimer’s disease or people at risk for the condition who could participate in future human studies inspired by these findings.
✕Less likely to help
Patients with advanced Alzheimer’s disease or other neurodegenerative conditions not matching the study’s focus may not benefit.
What this research studies
Alzheimer's disease currently has no cure, and new approaches are urgently needed. The researchers will explore how to increase slow-wave sleep activity in mice using acoustic stimulation, targeted drugs, and gene-based methods to boost brain clearance and potentially reduce amyloid plaques. They will measure brain waste removal in real time, check amyloid levels in brain tissue, and test cognitive-like performance in behavioral tasks. If successful, these strategies could form a basis for future therapies that support brain health in people with Alzheimer's disease. The work builds on advances linking deep sleep with brain cleaning and links these mechanisms to the claustrum and latexin biology.
Why it matters
Potential benefit: If successful, this research could lead to new, non-drug or gene-based therapies that enhance brain cleansing and slow disease progression in Alzheimer's patients.
How similar studies have gone: Previous work has shown that slow-wave activity relates to brain clearance and Alzheimer’s pathology, but applying three distinct approaches in parallel is novel and unproven in humans.
Where this research is happening
-
Boston VA Research Institute, INC.
Boston, United States Active
Researchers
- Principal investigator: Katsuki, Fumi — Boston VA Research Institute, INC.
- Study coordinator: Katsuki, Fumi
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.